(Q35753946)

10 August 2017

1 reference

title

Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? (English)

1 reference

10 August 2017

1 reference

Hirsch EC

1

1 reference

10 August 2017

language of work or name

1 reference

1 January 1992

1 reference

10 August 2017

1 reference

10 August 2017

volume

32 Suppl

1 reference

10 August 2017

page(s)

S88-93

1 reference

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410320715

Crossref

reference URL

Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410320715

Crossref

reference URL

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Glutathione peroxidase activity in Parkinson's disease brain

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-1328k in cultured hippocampal neurons

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Possible role of neuromelanin in the pathogenesis of Parkinson's disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

The effect of age on the non-haemin iron in the human brain.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Superoxide dismutase and Parkinson's disease.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/ANA.410320715

Identifiers

DOI

10.1002/ANA.410320715

1 reference

10 August 2017

1 reference